Timothy Affolter

882 total citations
7 papers, 115 citations indexed

About

Timothy Affolter is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Timothy Affolter has authored 7 papers receiving a total of 115 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Timothy Affolter's work include Protein Kinase Regulation and GTPase Signaling (2 papers), Cancer therapeutics and mechanisms (1 paper) and Advanced Breast Cancer Therapies (1 paper). Timothy Affolter is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (2 papers), Cancer therapeutics and mechanisms (1 paper) and Advanced Breast Cancer Therapies (1 paper). Timothy Affolter collaborates with scholars based in United States, Australia and United Kingdom. Timothy Affolter's co-authors include James G. Christensen, Kenneth Zasadny, Anthony Wong, Carleen Cullinane, Tim Nichols, Zhengming Yan, Patrick B. Lappin, Qin Zhang, Kyle Kuszpit and Peter J. O’Brien and has published in prestigious journals such as Clinical Cancer Research, Molecular Cancer Therapeutics and BMC Cancer.

In The Last Decade

Timothy Affolter

6 papers receiving 115 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timothy Affolter United States	6	37	30	30	23	22	7	115
Emel Ünal Türkiye	6	27 0.7×	16 0.5×	35 1.2×	7 0.3×	45 2.0×	13	162
Christian Beil Germany	5	38 1.0×	74 2.5×	16 0.5×	10 0.4×	14 0.6×	7	121
Neiwete Lomi India	8	56 1.5×	42 1.4×	34 1.1×	4 0.2×	17 0.8×	44	278
Dalia Alqunaibit United States	4	17 0.5×	25 0.8×	125 4.2×	14 0.6×	20 0.9×	7	181
Grant Ellsworth United States	6	23 0.6×	48 1.6×	26 0.9×	58 2.5×	11 0.5×	12	171
Thomas E. Bickett United States	10	12 0.3×	48 1.6×	71 2.4×	14 0.6×	20 0.9×	17	239
Cindy E. Owen United States	7	19 0.5×	13 0.4×	24 0.8×	10 0.4×	44 2.0×	18	161
Natalie Mitchell United States	6	32 0.9×	33 1.1×	20 0.7×	7 0.3×	3 0.1×	12	145
Conrad Rauber Germany	8	13 0.4×	36 1.2×	64 2.1×	10 0.4×	21 1.0×	16	172
J.J. Pérez-Venegas Spain	6	26 0.7×	13 0.4×	12 0.4×	4 0.2×	8 0.4×	10	149

Countries citing papers authored by Timothy Affolter

Since Specialization

Citations

This map shows the geographic impact of Timothy Affolter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Affolter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Affolter more than expected).

Fields of papers citing papers by Timothy Affolter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Affolter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Affolter. The network helps show where Timothy Affolter may publish in the future.

Co-authorship network of co-authors of Timothy Affolter

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Affolter. A scholar is included among the top collaborators of Timothy Affolter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Affolter. Timothy Affolter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Lee, Catherine, Ziyue Karen Jiang, Simon Planken, et al.. (2023). Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer. Molecular Cancer Therapeutics. 22(7). 891–900.

2.

Yanochko, Gina M., Timothy Affolter, Mark Evans, et al.. (2014). Investigation of Ocular Events Associated with Taprenepag Isopropyl, a Topical EP2 Agonist in Development for Treatment of Glaucoma. Journal of Ocular Pharmacology and Therapeutics. 30(5). 429–439. 11 indexed citations

3.

Eswaraka, Jeetendra, Anand Giddabasappa, Guangzhou Han, et al.. (2014). Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer. BMC Cancer. 14(1). 742–742. 15 indexed citations

4.

Leal, Mauricio, Qingcong Lin, Timothy Affolter, et al.. (2014). Phenotype of TPBG Gene Replacement in the Mouse and Impact on the Pharmacokinetics of an Antibody–Drug Conjugate. Molecular Pharmaceutics. 12(6). 1730–1737. 5 indexed citations

5.

Zhang, Cathy C., Zhengming Yan, Wenlin Li, et al.. (2011). [18F]FLT–PET Imaging Does Not Always “Light Up” Proliferating Tumor Cells. Clinical Cancer Research. 18(5). 1303–1312. 62 indexed citations

6.

Hirakawa, Brad, William R. Scott, G. Jayarama Bhat, et al.. (2010). Antisense Inhibition of S6 Kinase 1 Produces Improved Glucose Tolerance and Is Well Tolerated for 4 Weeks of Treatment in Rats. Pharmacology. 87(1-2). 11–23. 6 indexed citations

7.

Sykes, Jane E., et al.. (2007). Mycobacterium tuberculosis Complex Infection in a Dog. Journal of Veterinary Internal Medicine. 21(5). 1108–1112. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact